Continuous Glucose Monitoring Devices Market Size is USD 15.45 Billion in 2026

The global continuous glucose monitoring devices market, valued at USD 13.41 billion in 2025, is projected to reach USD 55.2 billion by 2035, growing at a CAGR of 15.20%, driven by rising diabetes prevalence, technological advancements, and increased demand for real-time glucose tracking solutions.

Continuous Glucose Monitoring Devices Market Statical Scope

The continuous glucose monitoring (CGM) devices are a comprehensive wearable medical device that keeps an eye on the sugar (glucose) level throughout the day with full persistence. This device calculates the glucose level in interstitial fluid without extending the time by measuring the glucose in blood. The standard system for standard care involves the use of a sensor, a transmitter, and a monitor. The commendable tracking and real-time warning alarms keep the market awake and aware of the growing advanced needs of the patient population, mainly the diabetes-stressed cohort.

The growing business and engagements among several regional leaders for smart systems and technologies are attracting more investment in the healthcare infrastructure. The self-monitoring is promoting the potential and awareness of the market by featuring home care settings/solutions.

Continuous Glucose Monitoring Devices Market Market Share, By Region, 2025 (%)

• North America – The North America regional segment dominated the market by 67% share, with the sincere involvement of the regional market leaders and improved reimbursement policies strengthening the regional market growth.
• Europe – Europe leads with 15% of the share, with the heavy adoption rate of automated insulin delivery systems. The isCGM and real-time CGMs are a tech boom for the regional segment to earn good revenue in this market.
• Asia Pacific – The segment leads by 10% with the unified CGM insulin pump systems and increasing diabetic population volume. The digital health adoption is the strength of the regional market to expand further in the long run.
• Latin America – Latin America covers 5% of the share with the well-framed coverage and availability of government perks and private insurance, focusing on the good health of diabetes patients in the region, mainly in Argentina and Brazil.
• Middle East & Africa – The MEA region acquires 3% of profit with the spur in digital healthcare and tech innovations, like smart wearable technology, which is a reason for more profit in the regional market. The modern, less invasive devices with sensors are a core advancement of the regional market.

Continuous Glucose Monitoring Devices Market Share, By Product, 2025 (%)

• Sensors – The sensors segment successfully acquires 40% of the share due to its rising demand rate and to achieve accuracy in terms of patient health safety. The integrability of sensors with smartphones through Bluetooth attracts the young and adult population.
• Device/Readers – The continued use of smartphones and awareness of apps stimulates the segment growth by 25%, while the NFC technology proves its compatibility with smartphones, and this segment will lock further engagements in the market.
• Applicators – The applicators lead with 20% of share due to their compact nature, according to the sensor's size, fitting as the best solution on the body. The comfort and long-standing wear promote the user-friendly applicators' role in this market.
• Transmitters – The segment rose by 15% with the sincere tech support to match the requirement of CGM settings already integrated with sensors. The Bluetooth connectivity is a strength of the segment, enabling access to real-time data sharing via connected mobile apps and automated insulin delivery systems.

Continuous Glucose Monitoring Devices Market Share, By Connectivity, 2025 (%)

• Bluetooth – The Bluetooth segment dominated the market by 58% of share, with its hassle-free direct connection to smartwatches and phones, making it easy to use. The enhanced integration and remote monitoring are bolstering the segmental growth.
• Near Field Communication (NFC) – The segment is fuelling more demand for this market with its commendable instant data transfer advantage and battery-free solution, securing 12% of the market share.
• 4G/Cellular – The segment acquires 30% of share with the rising demand for cloud-related analytics and RPM. The real-time data transmission is a boon for this segment to rise and seize opportunities to connect with the vast market businesses.

Continuous Glucose Monitoring Devices Market Share, By Indication, 2025 (%)

• Type 1 diabetes – The Type 1 diabetes segment dominated the market by 65% of share, with the confident, qualified HbA1c reduction and unification of automated insulin delivery systems marking prominent growth in this segmental market.
• Type 2 diabetes – The segment covers 35% of the share, with heavy registration of Type 2 diabetes patients. The proven benefits sign more deals with the remote monitoring sector to stimulate solutions in this segment.

Continuous Glucose Monitoring Devices Market Share, By Distribution Channel, 2025 (%)

• Pharmacies – The pharmacies segment dominated the market by 60% of share, with a valuable, profitable online and retail chain driving growth in this segment. The enhanced technology and pharmacist initiatives towards educating patients are fuelling growth in the segmental market.
• E-commerce – The e-commerce segment acquires the highest of 25%, with the rising consumer demand for robust devices and DTC subscription models generating more profit in the healthcare business. The wellness apps drive more growth in this segment.

Continuous Glucose Monitoring Devices Market Companies

• DexCom, Inc.
• Abbott Laboratories
• Medtronic plc
• Sensonics, Inc.
• Sinocare, Inc. (iCan CGM)
• i-SENS, Inc.
• Zhejiang POCTech Co., Ltd.
• GlucoRx Limited (AiDEX, Vixxa)
• F. Hoffmann-La Roche Ltd.
• Nemaura
• Bionime (RIGHTEST iFree CGM)

Continuous Glucose Monitoring Devices Market Segmentation

By Product

• Sensors
• Device/Readers
• Applicators
• Transmitters

By Connectivity

• Bluetooth
• 4G/Cellular
• Near Field Communication (NFC)

By Indication

• Type 1 Diabetes
• Type 2 Diabetes

By Distribution Channel

• Pharmacies
• E-commerce

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa